The Calmer Co Launches Taki Mai Kava Tinctures on Amazon USA
| Stock | The Calmer Co International Ltd (CCO.ASX) |
|---|---|
| Release Time | 23 Jun 2025, 9:41 a.m. |
| Price Sensitive | Yes |
The Calmer Co Launches Taki Mai Kava Tinctures on Amazon USA
- Taki Mai® 1oz and 4oz kava tinctures now available on Amazon USA
- Designed for direct use or mixing, fast-acting and portable
- Produced using organic cane alcohol extraction and premium Noble Kava
The Calmer Co. International Limited (ASX: CCO), a beverage company focused on kava and other natural products that support relaxation, aid sleep, and offer an alternative to alcohol, has announced the launch of its Taki Mai® 1oz and 4oz kava tinctures on Amazon USA. These tinctures are the first products in The Calmer Co.'s new US product launch, ahead of flavored Taki Mai kava shots and stick packs. The tinctures are designed for direct use or mixing, offering fast-acting and portable kava experience. They are produced using organic cane alcohol extraction and premium Noble Kava. This launch positions The Calmer Co. at the forefront of the evolving kava category in the U.S., as the company responds to clear demand for potent, versatile products that integrate seamlessly into wellness and relaxation routines. The US currently contributes 29% of The Calmer Co.'s revenue, a figure expected to grow significantly with the rollout of new product formats. Amazon subscription sales now account for 28% of monthly volume and continue to rise, demonstrating strong customer loyalty and demand for ongoing wellness solutions.
The Calmer Co. is well positioned to become a leading player in the fast-growing kava market, with Amazon forecasting 45% growth in kava product sales and the broader market expanding at over 16% CAGR. The Amazon tincture category alone is valued at over US$11.16 million, growing at 18% annually, providing a strategic entry point for the company's differentiated, efficacious Taki Mai® tinctures.